PARDES BIOSCIENCES, INC. Quarterly Debt-to-equity in % from Q3 2021 to Q2 2023

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Pardes Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q2 2023.
Pardes Biosciences, Inc. Debt-to-equity for the quarter ending June 30, 2023 was 6.52 %, a 18.3% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2023	6.52	+1.01	+18.3%	Jun 30, 2023
Q1 2023	7.16	-0.83	-10.4%	Mar 31, 2023
Q4 2022	6.16	-12.3	-66.7%	Dec 31, 2022
Q3 2022	4.37	+50		Sep 30, 2022
Q2 2022	5.51			Jun 30, 2022
Q1 2022	7.99			Mar 31, 2022
Q4 2021	18.5			Dec 31, 2021
Q3 2021	-45.7			Sep 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.